ArticleBMC health services research2022

The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy.

Féline E V Scheijmans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.